These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36983419)

  • 1. Epidemiology of Immune-Mediated Glomerulopathies before and after SARS-CoV-2 Vaccination: A Tertiary Referral Hospital Experience.
    Zamora JI; López-Martínez M; Patricio Liebana M; Leon Román JC; Bermejo S; Vergara A; Agraz I; Terrades NR; Azancot MA; Toapanta N; Gabaldon MA; Soler MJ
    J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Th1 Cytokines Signature in 2 Cases of IgA Nephropathy Flare after mRNA-Based SARS-CoV-2 Vaccine: Exploring the Pathophysiology.
    Martinez Valenzuela L; Oliveras L; Gomà M; Quiros E; Antón-Pámpols P; Gómez-Preciado F; Fulladosa X; Cruzado JM; Torras J; Draibe J
    Nephron; 2022; 146(6):564-572. PubMed ID: 35640535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry-protocol and preliminary data.
    Isnardi CA; Schneeberger EE; Kreimer JL; Luna PC; Echeverría C; Roberts K; de la Vega MC; Virasoro BM; Landi M; Quintana R; Exeni MED; Kogan N; Petkovic I; Pereira D; De Los Ángeles Correa M; Zelaya MD; Tissera Y; Elkin MSG; Pisoni CN; Alonso C; Cogo AK; Cosatti MA; García L; Retamozo C; de Los Ángeles Severina M; Nieto RE; Rosemffet M; Mussano E; Bertoli A; Savio VG; Cosentino V; Pons-Estel GJ
    Clin Rheumatol; 2022 Oct; 41(10):3199-3209. PubMed ID: 35760939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination.
    Watad A; De Marco G; Mahajna H; Druyan A; Eltity M; Hijazi N; Haddad A; Elias M; Zisman D; Naffaa ME; Brodavka M; Cohen Y; Abu-Much A; Abu Elhija M; Bridgewood C; Langevitz P; McLorinan J; Bragazzi NL; Marzo-Ortega H; Lidar M; Calabrese C; Calabrese L; Vital E; Shoenfeld Y; Amital H; McGonagle D
    Vaccines (Basel); 2021 Apr; 9(5):. PubMed ID: 33946748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A possible relationship between anti-SARS-CoV-2 vaccination and glomerular diseases: food for thought for the nephrologist].
    Rizzo M; Marino A; Sannino A; Urciuoli V; Capuano I; Pisani A
    G Ital Nefrol; 2022 Apr; 39(2):. PubMed ID: 35470996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease Flare and Reactogenicity in Patients With Rheumatic and Musculoskeletal Diseases Following Two-Dose SARS-CoV-2 Messenger RNA Vaccination.
    Connolly CM; Ruddy JA; Boyarsky BJ; Barbur I; Werbel WA; Geetha D; Garonzik-Wang JM; Segev DL; Christopher-Stine L; Paik JJ
    Arthritis Rheumatol; 2022 Jan; 74(1):28-32. PubMed ID: 34346185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune-mediated inflammatory diseases after anti-SARS-CoV-2 vaccines: new diagnoses and disease flares.
    Carubbi F; Alunno A; Santilli J; Natali L; Mancini B; Di Gregorio N; Del Pinto R; Viscido A; Grassi D; Ferri C
    RMD Open; 2022 Sep; 8(2):. PubMed ID: 36282905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of new onset glomerulonephritis after SARS-CoV-2 mRNA vaccination is not increased.
    Diebold M; Locher E; Boide P; Enzler-Tschudy A; Faivre A; Fischer I; Helmchen B; Hopfer H; Kim MJ; Moll S; Nanchen G; Rotman S; Saganas C; Seeger H; Kistler AD
    Kidney Int; 2022 Dec; 102(6):1409-1419. PubMed ID: 36096267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerular Disease in Temporal Association with SARS-CoV-2 Vaccination: A Series of 29 Cases.
    Caza TN; Cassol CA; Messias N; Hannoudi A; Haun RS; Walker PD; May RM; Seipp RM; Betchick EJ; Amin H; Ziadie MS; Haderlie M; Eduwu-Okwuwa J; Vancea I; Seek M; Elashi EB; Shenoy G; Khalillullah S; Flaxenburg JA; Brandt J; Diamond MJ; Frome A; Kim EH; Schlessinger G; Ulozas E; Weatherspoon JL; Hoerschgen ET; Fabian SL; Bae SY; Iqbal B; Chouhan KK; Karam Z; Henry JT; Larsen CP
    Kidney360; 2021 Nov; 2(11):1770-1780. PubMed ID: 35372991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abrupt worsening of occult IgA nephropathy after the first dose of SARS-CoV-2 vaccination.
    Fujita Y; Yoshida K; Ichikawa D; Shibagaki Y; Yazawa M
    CEN Case Rep; 2022 Aug; 11(3):302-308. PubMed ID: 34988883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hesitancy for SARS-CoV-2 vaccines and post-vaccination flares in patients with systemic lupus erythematosus.
    Mok CC; Chan KL; Tse SM
    Vaccine; 2022 Sep; 40(41):5959-5964. PubMed ID: 36085256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-COV-2 Infection, Vaccination, and Immune-Mediated Diseases: Results of a Single-Center Retrospective Study.
    Luchetti Gentiloni MM; Paci V; Marconi V; Gigli M; Benfaremo D; Sordillo R; Macchini C; Massaccesi L; Perna GP; Offidani AM; Moroncini G
    Front Immunol; 2022; 13():859550. PubMed ID: 35386714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections.
    Desmecht S; Tashkeev A; El Moussaoui M; Marechal N; Perée H; Tokunaga Y; Fombellida-Lopez C; Polese B; Legrand C; Wéry M; Mni M; Fouillien N; Toussaint F; Gillet L; Bureau F; Lutteri L; Hayette MP; Moutschen M; Meuris C; Vermeersch P; Desmecht D; Rahmouni S; Darcis G
    Front Immunol; 2022; 13():863554. PubMed ID: 35711445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-SARS-CoV-2 IgA and IgG in human milk after vaccination is dependent on vaccine type and previous SARS-CoV-2 exposure: a longitudinal study.
    Selma-Royo M; Bäuerl C; Mena-Tudela D; Aguilar-Camprubí L; Pérez-Cano FJ; Parra-Llorca A; Lerin C; Martínez-Costa C; Collado MC
    Genome Med; 2022 Apr; 14(1):42. PubMed ID: 35449030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De Novo Minimal Change Disease following Vaccination with the Pfizer/BioNTech SARS-CoV-2 Vaccine in a Living Kidney Donor.
    Marinaki S; Kolovou K; Liapis G; Skalioti C; Tsiakas S; Boletis I
    Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low frequency of disease flare in patients with rheumatic musculoskeletal diseases who received SARS-CoV-2 mRNA vaccine.
    Spinelli FR; Favalli EG; Garufi C; Cornalba M; Colafrancesco S; Conti F; Caporali R
    Arthritis Res Ther; 2022 Jan; 24(1):21. PubMed ID: 35016701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of prior SARS-CoV-2 infection on incidence of hospitalization and adverse events following mRNA SARS-CoV-2 vaccination: A nationwide, retrospective cohort study.
    Li LL; Zheng C; La J; Do NV; Monach PA; Strymish JM; Fillmore NR; Branch-Elliman W
    Vaccine; 2022 Feb; 40(8):1082-1089. PubMed ID: 35078665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 new infections among health-care workers after the first dose of the BNT162b2 mRNA COVID-19 vaccine. A hospital-wide cohort study.
    Guijarro C; Galán I; Martínez-Ponce D; Pérez-Fernández E; Goyanes MJ; Castilla V; Velasco M
    Clin Microbiol Infect; 2021 Nov; 27(11):1699.e1-1699.e4. PubMed ID: 34197936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between history of SARS-CoV-2 infection and severe systemic adverse events after mRNA COVID-19 vaccination among U.S. adults.
    Tompkins LK; Baggs J; Myers TR; Gee JM; Marquez PL; Kennedy SB; Peake D; Dua D; Hause AM; Strid P; Abara W; Rossetti R; Shimabukuro TT; Shay DK
    Vaccine; 2022 Dec; 40(52):7653-7659. PubMed ID: 36372665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.